8-K
Current Report
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-026779
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading auph-20221017.htm…